ArticleBMC public health2025
Association between sarcopenia and components of metabolic syndrome among Chinese older adults: a population-based longitudinal study using CHARLS.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Cardiometabolic index (CMI) and sarcopenia as predictors of all-cause and cardiovascular mortality in chronic kidney disease: a NHANES-based cohort study.Renal failure · 2026Article
- Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones.International journal of molecular sciences · 2026Article
- Article
- Visceral Adiposity, Rather than Reduced Appendicular Lean Mass, Characterizes Elderly Hip Fracture Patients with Type 2 Diabetes: A Cross-Sectional DXA Analysis.Journal of clinical medicine · 2026Article
- Risk prediction of sarcopenia in a large health checkup population: development and validation of a dynamic online nomogram.Frontiers in public health · 2026Article
- Sex-specific mediating role of serum uric acid in the association between dietary diversity and muscle strength in urban community-dwelling older adults.Frontiers in public health · 2026Article
- Unraveling the metabolic pathways between atherosclerosis and sarcopenia.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSarcopenia is an age-related loss of muscle mass and strength that affects quality of life in older adults and may also increase the risk of developing metabolic syndrome (MetS) and its components. This study aimed to explore the longitudinal association between sarcopenia and the components of MetS. Data for this study were derived from China Health and Retirement Longitudinal Survey (CHARLS).
methodsThe sample included 3,758 participants aged ≥ 60 years who were included in the baseline survey of CHARLS (2011) and followed up until 2015. Sarcopenia status was defined according to the 2019 Asian Working Group for Sarcopenia (AWGS2019). The diagnostic components of MetS were assessed according to the clinical criteria outlined in the 2022 expert consensus on the management of MetS in older adults in China. Cox proportional hazards regression (HR) models were used to evaluate the effect of sarcopenia the risk factors of MetS.
resultsIn this study, 1,252 individuals with sarcopenia and 2,506 individuals without sarcopenia were included. During follow-up, 489 MetS cases were observed among those without MetS at baseline. Participants with sarcopenia exhibited significantly lower body mass index (BMI), waist circumference, triglycerides (TG), and blood glucose levels (all p < 0.001) compared to those without sarcopenia. After adjusting for sex, age, education, marital status, smoking, alcohol consumption, and physical activity, hazard ratios (HR) in the sarcopenia group were significantly elevated for abdominal obesity (HR 8.24, 95% CI 6.56-10.27; p < 0.001), hypertriglyceridemia (HR 2.12, 95% CI 1.40-3.20; p < 0.05), and MetS (HR 5.33, 95% CI 4.01-7.08; p < 0.001). In the BMI subgroup, the risk of sarcopenia was found to increase in elderly individuals within the low BMI of 18.5-23.9 kg/m
conclusionSarcopenia was significantly associated with specific components of MetS, particularly abdominal obesity and hypertriglyceridemia. In addition, low BMI emerged as a key factor related to sarcopenia development among older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.